| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |